Clinical manifestations of ocular toxoplasmosis

E Delair, P Latkany, AG Noble, P Rabiah… - Ocular immunology …, 2011 - Taylor & Francis
Clinical manifestations of ocular toxoplasmosis are reviewed. Findings of congenital and
acute acquired ocular toxoplasmosis include retinal scars, white-appearing lesions in the …

Ocular perfusion abnormalities in diabetes

TA Ciulla, A Harris, P Latkany, HC Piper… - Acta …, 2002 - Wiley Online Library
Purpose: To review the role of ocular perfusion in the pathophysiology of diabetic
retinopathy, one of the leading causes of irreversible blindness in the industrialized world …

Outcome of treatment for congenital toxoplasmosis, 1981–2004: the national collaborative Chicago-based, congenital toxoplasmosis study

…, M Mets, E Holfels, S Withers, P Latkany… - Clinical Infectious …, 2006 - academic.oup.com
Background. Without treatment, congenital toxoplasmosis has recurrent, recrudescent,
adverse outcomes. Long-term follow-up of infants with congenital toxoplasmosis treated …

Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life

…, K Kasza, J Jalbrzikowski, AG Noble, P Latkany… - American journal of …, 2008 - Elsevier
PURPOSE: To determine the incidence of new chorioretinal lesions in children with
toxoplasmosis diagnosed after, and therefore not treated during, their first year. DESIGN …

[HTML][HTML] Associations among visual acuity and vision-and health-related quality of life among patients in the multicenter uveitis steroid treatment trial

…, JP Dunn, GN Holland, P Latkany… - … & visual science, 2012 - iovs.arvojournals.org
Purpose.: To evaluate the associations between visual acuity and self-reported visual
function; visual acuity and health-related quality of life (QoL) metrics; a summary measure of …

[HTML][HTML] Building programs to eradicate toxoplasmosis part I: Introduction and overview

…, S Withers, T Hull, C Su, M Blair, P Latkany… - Current Pediatrics …, 2022 - Springer
Abstract Purpose of Review Review building of programs to eliminate Toxoplasma
infections. Recent Findings Morbidity and mortality from toxoplasmosis led to programs in …

Longitudinal study of new eye lesions in treated congenital toxoplasmosis

L Phan, K Kasza, J Jalbrzikowski, AG Noble, P Latkany… - Ophthalmology, 2008 - Elsevier
OBJECTIVE: To determine the incidence of new chorioretinal lesions in patients with
congenital toxoplasmosis who were treated throughout their first year of life. DESIGN …

Multifocal choroiditis in patients with familial juvenile systemic granulomatosis

PA Latkany, DA Jabs, JR Smith, JT Rosenbaum… - American journal of …, 2002 - Elsevier
PURPOSE: To document clinical features of uveitis in patients with familial juvenile systemic
granulomatosis. DESIGN: Retrospective chart review. METHODS: Ophthalmologic …

Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis

R McLeod, AR Khan, GA Noble, P Latkany… - The Pediatric …, 2006 - journals.lww.com
A 7-year-old with congenital toxoplasmosis who took pyrimethamine and sulfadiazine for
reactivated chorioretinitis developed fever, severe cutaneous involvement, swelling …

Factors predicting visual acuity outcome in intermediate, posterior, and panuveitis: the Multicenter Uveitis Steroid Treatment (MUST) trial

JH Kempen, ML Van Natta, MM Altaweel… - American journal of …, 2015 - Elsevier
Purpose To identify factors associated with best-corrected visual acuity (BCVA) presentation
and 2-year outcome in 479 intermediate, posterior, and panuveitic eyes. Design Cohort …